Jushi Holdings (JUSHF) Free Cash Flow Growth (1y) (2022 - 2026)
Jushi Holdings (JUSHF) Free Cash Flow Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 10.34% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | -13.65% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 56.40% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | -5.85% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | -29.32% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 166.91% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 44.93% |
| 10 | Jushi Holdings | 81.25 Mn | 41.54 Mn | 29.88 Mn | 29.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.34% |
| Dec 31, 2025 | -5.36% |
| Sep 30, 2025 | 272.19% |
| Jun 30, 2025 | -151.66% |
| Mar 31, 2025 | -1.08% |
| Dec 31, 2024 | 215.71% |
| Sep 30, 2024 | 144.97% |
| Jun 30, 2024 | 176.49% |
| Mar 31, 2024 | 185.98% |
| Dec 31, 2023 | -73.23% |
| Sep 30, 2023 | 15.23% |
| Jun 30, 2023 | -211.95% |
| Mar 31, 2023 | 83.55% |
| Dec 31, 2022 | -82.96% |
| Sep 30, 2022 | 82.79% |